Angiotensins and Alzheimer's disease: a bench to bedside overview.
The pathology of Alzheimer's disease (AD) features amyloid beta peptide deposition, intracellular neurofibrillary tangles and deficits in the cholinergic pathway. Abnormal blood pressure is recognised as a risk factor for the development of AD, although the underlying mechanisms remain unproven. This review proposes angiotensins and associated enzymatic pathways as important mediators of recognised but undefined links between blood pressure and AD. Evidence in support of this involvement translates consistently from the most basic in vitro, in vivo and ex vivo experimental paradigms to more complex human-based observational and experimental studies, which also fortunately offer potential for therapeutic interventions against AD.
Kehoe
Patrick G
PG
Dementia Research Group, Institute of Clinical Neurosciences, Department of Clinical Science at North Bristol, University of Bristol, Frenchay Hospital, Bristol BS16 1LE, UK. Patrick.Kehoe@bristol.ac.uk.
Biol Psychiatry. 1986 Dec;21(14):1365-81
3024746
Drugs Aging. 2002;19(10):723-32
12390049
BMC Neurosci. 2008 Dec 03;9 Suppl 2:S14
19090987
Neurol Res. 2006 Sep;28(6):605-11
16945211
Lancet Neurol. 2007 Apr;6(4):373-8
17362841
J Neurochem. 2007 Jun;101(5):1172-84
17286590
Biochem Biophys Res Commun. 2004 May 21;318(1):187-91
15110771
Ann Hum Genet. 2005 Mar;69(Pt 2):227-32
15720304
J Cardiovasc Pharmacol. 1992;19 Suppl 6:S63-71
1382167
Expert Opin Biol Ther. 2008 Nov;8(11):1669-73
18847303
Curr Alzheimer Res. 2006 Feb;3(1):71-3
16472206
Nat Genet. 2007 Jan;39(1):17-23
17192785
Am J Hypertens. 1989 Apr;2(4):294-306
2706094
J Hypertens. 1996 Jun;14(6):719-27
8793694
J Neurosci. 2007 Aug 8;27(32):8628-35
17687040
J Clin Invest. 1990 Oct;86(4):1343-6
1976655
Rapid Commun Mass Spectrom. 2008;22(2):231-9
18085519
Am J Geriatr Psychiatry. 2008 Nov;16(11):883-92
18978249
Expert Opin Ther Targets. 2004 Feb;8(1):7-14
14996614
Am J Epidemiol. 2005 Aug 15;162(4):305-17
16033878
Neurogenetics. 2009 Feb;10(1):19-25
18830724
Eur J Pharmacol. 2008 Jun 24;588(1):18-25
18495113
J Alzheimers Dis. 2009;16(3):609-18
19276555
J Clin Invest. 2007 Nov;117(11):3393-402
17965777
Neurosci Lett. 2002 Aug 16;328(3):314-8
12147333
J Renin Angiotensin Aldosterone Syst. 2005 Dec;6(3):121-31
16525942
Brain Pathol. 2008 Apr;18(2):240-52
18363935
Am J Hum Genet. 2006 May;78(5):871-877
16642441
Neurochem Int. 2008 Nov;53(5):103-11
18602955
Neuropathol Appl Neurobiol. 2008 Apr;34(2):181-93
17973905
J Hypertens. 1999 Dec;17(12 Pt 2):1813-9
10703873
Brain Res. 1985 Mar 4;328(2):215-21
2985183
Alzheimer Dis Assoc Disord. 1993 Summer;7(2):105-11
8347328
Neurobiol Dis. 2007 Apr;26(1):27-35
17270454
Curr Alzheimer Res. 2005 Jan;2(1):29-35
15977987
Lancet Neurol. 2008 Aug;7(8):683-9
18614402
Cell Tissue Res. 2006 Nov;326(2):599-616
16555051
Neurogenetics. 2009 Feb;10(1):13-7
18813964
Arch Neurol. 2008 Jan;65(1):45-53
17998437
J Gerontol A Biol Sci Med Sci. 2005 Jan;60(1):67-73
15741285
J Renin Angiotensin Aldosterone Syst. 2003 Jun;4(2):80-93
12806589
Am J Transl Res. 2009 Jan 18;1(2):163-77
19956428
J Hum Hypertens. 2003 Nov;17(11):781-5
14578918
Am J Med Genet B Neuropsychiatr Genet. 2009 Jul 5;150B(5):721-35
19105203
Neurol Res. 2003 Sep;25(6):675-80
14503023
Geriatrics. 2005 Jan;60(1):20-2, 24
15700945
Eur J Clin Chem Clin Biochem. 1993 Aug;31(8):495-7
8218581
J Alzheimers Dis. 2008 Aug;14(4):453-7
18688098